Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | Oncoquest-L vaccine |
Synonyms | |
Therapy Description |
Oncoquest-L vaccine is a cancer vaccine comprising liposomal-encapsulated patient-specific proteins combined with IL-2, which may induce immune response against tumors expressing those proteins (NCI Drug Dictionary). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Oncoquest-L vaccine | autologous tumor cell proteoliposome chronic lymphocytic leukemia vaccine | Oncoquest-L vaccine is a cancer vaccine comprising liposomal-encapsulated patient-specific proteins combined with IL-2, which may induce immune response against tumors expressing those proteins (NCI Drug Dictionary). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT02194751 | Phase II | Oncoquest-L vaccine | Oncoquest-L Vaccine in Patients With Previously Untreated Stage III or IV, Asymptomatic, Non-bulky Follicular Lymphoma | Not yet recruiting | USA | 0 |